Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus

Although drugs used in renal transplant recipients such as steroids, cyclosporine, and particularly, tacrolimus have diabetogenic potential, diabetic ketoacidosis is uncommon. There are few data concerning the long-term follow-up of these patients. Diabetic ketoacidosis occurred in a renal transplan...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation proceedings 2004-06, Vol.36 (5), p.1407-1410
Main Authors: Ersoy, A, Ersoy, C, Tekce, H, Yavascaoglu, I, Dilek, K
Format: Article
Language:English
Subjects:
Adult
Biological and medical sciences
Diabetic Ketoacidosis - diagnosis
Drug Therapy, Combination
Female
Humans
Immunosuppressive Agents - adverse effects
Kidney Transplantation - immunology
Medical sciences
Peritoneal Dialysis, Continuous Ambulatory
Postoperative Complications - diagnosis
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the urinary system
Tacrolimus - adverse effects
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Although drugs used in renal transplant recipients such as steroids, cyclosporine, and particularly, tacrolimus have diabetogenic potential, diabetic ketoacidosis is uncommon. There are few data concerning the long-term follow-up of these patients. Diabetic ketoacidosis occurred in a renal transplant recipient following de novo development associated with tacrolimus.
ISSN:0041-1345
1873-2623
DOI:10.1016/j.transproceed.2004.04.080